as 07-29-2025 4:00pm EST
Imunon Inc is a clinical-stage biotechnology company focused on advancing a portfolio of treatments that harness the body's natural mechanisms to generate safe, effective, and durable responses across various human diseases, constituting a differentiating approach from conventional therapies. It is developing its non-viral DNA technology across its modalities. Its clinical program, IMNN-001, is a DNA-based immunotherapy for the localized treatment of ovarian cancer that has completed Phase II clinical studies. Additionally, the Company has entered a first-in-human study of its COVID-19 booster vaccine (IMNN-101).
Upcoming Earnings Alert:
Get ready for potential market movements as Imunon Inc. IMNN prepares to release earnings report on 05 Aug 2025.
Founded: | 1982 | Country: | United States |
Employees: | N/A | City: | LAWRENCEVILLE |
Market Cap: | 12.1M | IPO Year: | 1985 |
Target Price: | $210.00 | AVG Volume (30 days): | 292.8K |
Analyst Decision: | Buy | Number of Analysts: | 2 |
Dividend Yield: | N/A | Dividend Payout Frequency: | N/A |
EPS: | -20.86 | EPS Growth: | N/A |
52 Week Low/High: | $5.55 - $54.75 | Next Earning Date: | 08-05-2025 |
Revenue: | N/A | Revenue Growth: | N/A |
Revenue Growth (this year): | N/A | Revenue Growth (next year): | N/A |
IMNN Breaking Stock News: Dive into IMNN Ticker-Specific Updates for Smart Investing
Zacks Small Cap Research
a month ago
Zacks Small Cap Research
a month ago
GlobeNewswire
a month ago
GlobeNewswire
a month ago
GlobeNewswire
2 months ago
GlobeNewswire
2 months ago
GlobeNewswire
2 months ago
Clinical Trials Arena
2 months ago
The information presented on this page, "IMNN Imunon Inc. - Stocks Price | History | Analysis", including historical data, forecasts, news, insider information, and predictions, is provided for educational purposes only. It should not be considered as financial advice or a recommendation to buy or sell any securities. Decisions regarding investments should be made only after careful consideration and consultation with a qualified financial advisor. We do not endorse or guarantee the accuracy or reliability of the information provided, and we disclaim any liability for financial losses incurred as a result of decisions made based on the information presented.